MCFA alleviate H2 O2 -induced oxidative stress in AML12 cells via the ERK1/2/Nrf2 pathway

Lipids. 2022 May;57(3):153-162. doi: 10.1002/lipd.12339. Epub 2022 Mar 9.

Abstract

Oxidative stress is an important factor in the occurrence and development of liver disease. Medium-chain fatty acids (MCFAs) have potential antioxidant function, whereas the exact underlying mechanism of MCFA in oxidative injury of hepatocytes remains unclear. In our present study, three different MCFAs, 8-carbon octanoic acid (OA), 10-carbon capric acid (CA), and 12-carbon lauric acid (LA), have been performed to observe their protective action for hepatocyte under the H2 O2 challenge. The result showed that MCFA treatment significantly increased the cell viability, T-AOC, and expression of antioxidant-related genes in AML12 cells under oxidative stress condition, and reduced reactive oxygen species (ROS) production. Moreover, MCFA treatment significantly increased the protein expression of Nrf2 and the phosphorylation level of ERK1/2; LA treatment significantly promoted the Nrf2 nuclear translocation. With a further test, the rescue ability of MCFA was blocked by treating with the ERK inhibitor U0126. Overall, our data suggested that MCFA treatment has positive impact on protecting AML12 cells against oxidative stress through ERK1/2/Nrf2 pathway.

Keywords: ERK1/2 signaling pathway; Nrf2; medium-chain fatty acids; oxidative stress.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antioxidants* / metabolism
  • Antioxidants* / pharmacology
  • Carbon
  • MAP Kinase Signaling System
  • NF-E2-Related Factor 2* / genetics
  • NF-E2-Related Factor 2* / metabolism
  • Oxidative Stress
  • Reactive Oxygen Species / metabolism

Substances

  • Antioxidants
  • NF-E2-Related Factor 2
  • Reactive Oxygen Species
  • Carbon